Characterization of lysine crotonylation-related lncRNAs for prognostic assessment and immune response in glioma. [PDF]
Song M+9 more
europepmc +1 more source
Chromenone Derivatives as CRM1 Inhibitors for Targeting Glioblastoma
Chromenone derivatives are synthesized and evaluated as inhibitors of chromosome region maintenance 1‐mediated nuclear export, targeting glioblastoma cells. Active compounds demonstrate structure‐ and dose‐dependent inhibition, supported by structure–activity relationships and molecular docking studies.
Salvatore Princiotto+10 more
wiley +1 more source
Comparative efficacy of glioma treatment strategies: an umbrella review of meta-analyses. [PDF]
Yang E+6 more
europepmc +1 more source
Specific visualization of glioma cells in living low-grade tumor tissue. [PDF]
Arndt-Jovin, D.+8 more
core +1 more source
Beyond Histones: Unveiling the Functional Roles of Protein Acetylation in Prokaryotes and Eukaryotes
ABSTRACT Lysine acetylation plays a crucial role in cellular processes and is found across various evolutionary organisms. Recent advancements in proteomic techniques revealed the presence of acetylation in thousands of non‐histone proteins. Here, we conducted extensive meta‐analysis of 48 acetylomes spanning diverse organisms, including archaea ...
Bruno Sousa Bonifácio+6 more
wiley +1 more source
The Effects of Castration on the Induction of Experimental Gliomas in Male Rats
J. W. Hopewell
openalex +1 more source
Integrative analysis of crotonylation-associated genes reveals prognostic and therapeutic targets in gliomas. [PDF]
Yin B, Fan Z, Yu P, Li J, Wang Y, Shu M.
europepmc +1 more source
A bioresponsive hydrogel based on hyaluronic acid crosslinked with a MMP inhibitor (HA‐MMPI) is generated to modulate the glioblastoma multiforme (GBM) microenvironment. In preliminary tests with 3D U87 models, HA‐MMPI selectively inhibits MMP‐2, reducing cell migration.
Federica Barbugian+13 more
wiley +1 more source
Bibliometric and visualization analysis of glioma pharmacotherapy from 2020 to 2024. [PDF]
Hong X+8 more
europepmc +1 more source
Abstract A pediatric‐friendly powder for oral suspension (PfOS) of tovorafenib, a type II RAF inhibitor, was developed for patients with difficulty swallowing tablets. This open‐label, randomized, phase 1 study (QSC205140) evaluated the taste/palatability of PfOS formulations (n = 12), the relative bioavailability of the PfOS versus tablet formulation,
Yang Zhang+6 more
wiley +1 more source